Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travacom in open-angle glaucoma or ocular hypertension
NCT01510132Phase 4Withdrawn
- Sponsor
- Alcon Inc.
- Start
- Jan 2012
- Primary completion
- Jan 2012
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of travoprost + timolol in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Planned start Jan 2012; status: withdrawn.
02
Drugs
travoprost + timolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01510132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01510132.